BOSTON, Aug. 4, 2020 /PRNewswire/ — Genuity Science, a U.S.-headquartered contract genomics and data-sourcing, -analytics and -insights organization, today announces an agreement with Nashville...read more
Category - Drug discovery
Genomics England launches next-generation research platform central to UK COVID-19 response
British tech company Lifebit and Amazon Web Services to support a dedicated environment for researchers working on COVID-19 vaccines and treatments Genomics England (GEL) has today launched a next-generation genomic...read more
Bluebee’s coherent data strategy set to unify Illumina’s data analytics products
This month’s attention-grabbing headlines in the field of genomics, genetics, and precision medicine can undoubtedly be attributed to the acquisition of Bluebee by Illumina. I spoke with Hans Cobben, CEO of Bluebee and...read more
Archived news – SARS-CoV-2 vaccine development
Merck to Acquire Austrian Vaccine Maker Themis Bioscience to enter COVID-19 race (May 26) – Themis has a broad pipeline of vaccine candidates and immune-modulatory therapies developed using its innovative measles...read more
